April 10, 2019, University of Western Ontario, via Medical Xpress 

New technology developed at Western University is providing an improved way for radiation oncologists to deliver treatment to women with gynaecological cancers, including vaginal, cervical, and uterine cancer. 

Read more.

April 10, 2019, Primary Care Today

The "simple, non-invasive" Congo Red Dot Paper Test detected preeclampsia in 3 minutes, significantly faster than the current gold standard, according to findings recently published in EClinical Medicine.

April 8, 2019, MedPage Today 

Within the 5 years following a diagnosis for stage I or II breast cancer, 21% of patients stop seeing physicians for follow-up care, according to a study in the Journal of Oncology Practice. 

Read more.

April 2, 2019, MedPage Today 

Total deaths for women with HIV and their children are projected to be lower with dolutegravir-based (Tivicay) antiretroviral therapy (ART) versus efavirenz-based (Sustiva) ART, a model-based analysis found. 

Read more.

March 29, 2019, HealthDay News 

A new study suggests that the fewer menstrual periods a woman has in her lifetime, the higher her risk of dementia — though the reasons, for now, are unclear. The study was based on close to 16,000 women. It found that those who started having periods at age 16 or later were more likely to develop dementia than women who started menstruating at a more typical age. The same was true of women who went through menopause relatively early. 

Read more.

March 28, 2019, Oncology Nursing News 

The U.S. Food and Drug Administration announced March 27 that it is working to update mammography regulations, expanding the amount of information that mammography facilities must give patients and healthcare professionals. In turn, this would result in more informed decision-making — especially when it comes to breast cancer diagnoses. 

Read more.

March 27, 2019, MedPage Today

NEW ORLEANS -- Walking downhill on a treadmill within an hour after eating produced a large osteogenic response in postmenopausal women with diabetes -- an effect not seen with uphill walking, a researcher said here.

Read more.

March 26, 2019, MedPage Today 

Children exposed to HIV in utero, but who remained uninfected, appeared to be predisposed to obesity and reactive airway disease later in life, a registry study found. 

Read more.

March 25, 2019, MedPage Today 

Levothyroxine treatment failed to increase the rate of live births among euthyroid women with thyroid peroxidase antibodies (TPO) and had a history of miscarriage or infertility, according to the TABLET trial. 

Read more.

March 21, 2019, MD Magazine 

The U.S. Food and Drug Administration (FDA) has approved brexanolone injection (Zulresso) as the first therapy indicated for the treatment of postpartum depression (PPD) in adult women. The therapy, which was approved for intravenous (IV) use in women enrolled in the Zulresso REMS Program, will only be available through the program, and administered by a care provider in a certified healthcare facility. Women treated with the drug are administered a continuous 60-hour IV infusion. 

Read more.